595 related articles for article (PubMed ID: 24291390)
1. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of endothelin 1 (EDN1) and endothelin receptor type A (EDNRA) gene polymorphisms in Hashimoto's thyroiditis.
Aydin AF; Vural P; Oruç ÇU; Doğru-Abbasoğlu S; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jul; 21(1):181-5. PubMed ID: 24815860
[TBL] [Abstract][Full Text] [Related]
3. G-231A and G+70C Polymorphisms of Endothelin Receptor Type-A Gene could Affect the Psoriasis Area and Severity Index Score and Endothelin 1 Levels.
Okan G; Yıldız Z; Gökdemir G; Yorulmaz E; Vural P; Doğru-Abbasoğlu S; Uysal M
Indian J Dermatol; 2015; 60(2):211. PubMed ID: 25814726
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
Vural P; Baki M; Doğru-Abbasoğlu S; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2012 Oct; 14(2):133-7. PubMed ID: 22771446
[TBL] [Abstract][Full Text] [Related]
5. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer.
Aydin AF; Vural P; Doğru-Abbasoğlu S; Çil E
Mol Biol Rep; 2019 Feb; 46(1):199-205. PubMed ID: 30411193
[TBL] [Abstract][Full Text] [Related]
6. The Evaluation of Endothelin-1 and Endothelin Receptor Type A Gene Polymorphisms in Patients with Vitiligo.
Bingül İ; Aydıngöz İE; Vural P; Doğru-Abbasoğlu S; Uysal M
Indian J Dermatol; 2016; 61(1):118. PubMed ID: 26955120
[TBL] [Abstract][Full Text] [Related]
7. Association between glaucoma and gene polymorphism of endothelin type A receptor.
Ishikawa K; Funayama T; Ohtake Y; Kimura I; Ideta H; Nakamoto K; Yasuda N; Fukuchi T; Fujimaki T; Murakami A; Asaoka R; Hotta Y; Kanamoto T; Tanihara H; Miyaki K; Mashima Y
Mol Vis; 2005 Jun; 11():431-7. PubMed ID: 15988412
[TBL] [Abstract][Full Text] [Related]
8. Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene increases the risk of developing Graves' disease.
Doğru-Abbasoğlu S; Vural P; Baki M; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jun; 20(2):366-9. PubMed ID: 24742542
[TBL] [Abstract][Full Text] [Related]
9. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
10. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
11. Endothelin axis polymorphisms in patients with scleroderma.
Fonseca C; Renzoni E; Sestini P; Pantelidis P; Lagan A; Bunn C; McHugh N; Welsh KI; Du Bois RM; Denton CP; Black C; Abraham D
Arthritis Rheum; 2006 Sep; 54(9):3034-42. PubMed ID: 16947775
[TBL] [Abstract][Full Text] [Related]
12. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
[TBL] [Abstract][Full Text] [Related]
13.
Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
[TBL] [Abstract][Full Text] [Related]
14. ICAM1 K469E and E-selectin S128R polymorphisms could predispose to increased autoantibody production and TSH suppression in Graves' disease.
Kanmaz-Özer M; Doğru-Abbasoğlu S; Vural P; Özderya A; Karadağ B; Uysal M
Mol Biol Rep; 2013 Mar; 40(3):2717-22. PubMed ID: 23242661
[TBL] [Abstract][Full Text] [Related]
15. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
16. Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.
Kuś A; Szymański K; Jurecka-Lubieniecka B; Pawlak-Adamska E; Kula D; Miśkiewicz P; Bolanowski M; Płoski R; Bossowski A; Daroszewski J; Jarząb B; Bednarczuk T
J Hum Genet; 2017 Mar; 62(3):373-377. PubMed ID: 27829681
[TBL] [Abstract][Full Text] [Related]
17. Effect of SNP polymorphisms of EDN1, EDNRA, and EDNRB gene on ischemic stroke.
Zhang L; Sui R
Cell Biochem Biophys; 2014 Sep; 70(1):233-9. PubMed ID: 24633486
[TBL] [Abstract][Full Text] [Related]
18. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
Khalilzadeh O; Mojazi Amiri H; Tahvildari M; Anvari M; Esteghamati A; Mobarra Z; Tehranchinia Z; Rashidi A; Amirzargar A
Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
[TBL] [Abstract][Full Text] [Related]
19. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease.
Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G
Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345
[TBL] [Abstract][Full Text] [Related]
20. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
